India
· Delayed Price · Currency is INR Zydus Wellness Statistics
Total Valuation
Zydus Wellness has a market cap or net worth of INR 127.38 billion. The enterprise value is 128.16 billion.
| Market Cap | 127.38B |
| Enterprise Value | 128.16B |
Important Dates
The last earnings date was Friday, May 30, 2025.
| Earnings Date | May 30, 2025 |
| Ex-Dividend Date | Jul 11, 2025 |
Share Statistics
Zydus Wellness has 63.63 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 63.63M |
| Shares Outstanding | 63.63M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 0.95% |
| Owned by Institutions (%) | 22.96% |
| Float | 18.63M |
Valuation Ratios
The trailing PE ratio is 36.72 and the forward PE ratio is 30.55.
| PE Ratio | 36.72 |
| Forward PE | 30.55 |
| PS Ratio | 4.70 |
| PB Ratio | 2.25 |
| P/TBV Ratio | 15.22 |
| P/FCF Ratio | 40.60 |
| P/OCF Ratio | 33.52 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.74, with an EV/FCF ratio of 40.86.
| EV / Earnings | 36.95 |
| EV / Sales | 4.73 |
| EV / EBITDA | 33.74 |
| EV / EBIT | 36.47 |
| EV / FCF | 40.86 |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.48 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.50 |
| Debt / FCF | 0.60 |
| Interest Coverage | 29.28 |
Financial Efficiency
Return on equity (ROE) is 6.29% and return on invested capital (ROIC) is 3.80%.
| Return on Equity (ROE) | 6.29% |
| Return on Assets (ROA) | 3.49% |
| Return on Invested Capital (ROIC) | 3.80% |
| Return on Capital Employed (ROCE) | 6.17% |
| Revenue Per Employee | 26.87M |
| Profits Per Employee | 3.44M |
| Employee Count | 1,008 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.59 |
Taxes
In the past 12 months, Zydus Wellness has paid 119.00 million in taxes.
| Income Tax | 119.00M |
| Effective Tax Rate | 3.32% |
Stock Price Statistics
The stock price has increased by +9.30% in the last 52 weeks. The beta is -0.07, so Zydus Wellness's price volatility has been lower than the market average.
| Beta (5Y) | -0.07 |
| 52-Week Price Change | +9.30% |
| 50-Day Moving Average | 1,854.58 |
| 200-Day Moving Average | 1,878.72 |
| Relative Strength Index (RSI) | 59.85 |
| Average Volume (20 Days) | 5,646 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zydus Wellness had revenue of INR 27.09 billion and earned 3.47 billion in profits. Earnings per share was 54.52.
| Revenue | 27.09B |
| Gross Profit | 14.31B |
| Operating Income | 3.51B |
| Pretax Income | 3.59B |
| Net Income | 3.47B |
| EBITDA | 3.80B |
| EBIT | 3.51B |
| Earnings Per Share (EPS) | 54.52 |
Balance Sheet
The company has 1.10 billion in cash and 1.88 billion in debt, giving a net cash position of -787.00 million or -12.37 per share.
| Cash & Cash Equivalents | 1.10B |
| Total Debt | 1.88B |
| Net Cash | -787.00M |
| Net Cash Per Share | -12.37 |
| Equity (Book Value) | 56.72B |
| Book Value Per Share | 891.16 |
| Working Capital | 3.59B |
Cash Flow
In the last 12 months, operating cash flow was 3.80 billion and capital expenditures -663.00 million, giving a free cash flow of 3.14 billion.
| Operating Cash Flow | 3.80B |
| Capital Expenditures | -663.00M |
| Free Cash Flow | 3.14B |
| FCF Per Share | 49.30 |
Margins
Gross margin is 52.82%, with operating and profit margins of 12.97% and 12.81%.
| Gross Margin | 52.82% |
| Operating Margin | 12.97% |
| Pretax Margin | 13.25% |
| Profit Margin | 12.81% |
| EBITDA Margin | 14.02% |
| EBIT Margin | 12.97% |
| FCF Margin | 11.58% |
Dividends & Yields
This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 0.30%.
| Dividend Per Share | 6.00 |
| Dividend Yield | 0.30% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.17% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.31% |
| Earnings Yield | 2.72% |
| FCF Yield | 2.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |